Masaaki Mizui

1.0k total citations
23 papers, 828 citations indexed

About

Masaaki Mizui is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, Masaaki Mizui has authored 23 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Hepatology and 3 papers in Hematology. Recurrent topics in Masaaki Mizui's work include Hepatitis C virus research (19 papers), Hepatitis B Virus Studies (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Masaaki Mizui is often cited by papers focused on Hepatitis C virus research (19 papers), Hepatitis B Virus Studies (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Masaaki Mizui collaborates with scholars based in Japan, United States and Switzerland. Masaaki Mizui's co-authors include Hiroshi Yoshizawa, Junko Tanaka, Keiko Katayama, Yuzo Miyakawa, Yutaka Komiya, Junko Kumagai, Hisao Yugi, Retsuji Yamanaka, Kou Suzuki and Junko Matsuo and has published in prestigious journals such as Journal of Clinical Microbiology, Biomedicine & Pharmacotherapy and Journal of Medical Virology.

In The Last Decade

Masaaki Mizui

22 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Mizui Japan 14 699 630 68 60 35 23 828
Martí Vall Spain 9 578 0.8× 547 0.9× 114 1.7× 86 1.4× 19 0.5× 17 831
José María Sánchez-Tapias Spain 11 1.3k 1.8× 1.2k 2.0× 85 1.3× 27 0.5× 22 0.6× 13 1.4k
Vincenzo Guadagnino Italy 15 752 1.1× 822 1.3× 104 1.5× 18 0.3× 70 2.0× 42 950
Zelma Buskell‐Bales United States 8 1.1k 1.5× 1.1k 1.7× 84 1.2× 18 0.3× 42 1.2× 8 1.3k
Rabab Fouad Egypt 17 617 0.9× 616 1.0× 92 1.4× 31 0.5× 32 0.9× 49 800
J. Camps Spain 8 485 0.7× 539 0.9× 78 1.1× 37 0.6× 115 3.3× 20 663
L Viladomiu Spain 14 1.5k 2.2× 1.6k 2.5× 179 2.6× 19 0.3× 73 2.1× 25 1.8k
David Ipe United States 11 959 1.4× 437 0.7× 258 3.8× 25 0.4× 57 1.6× 19 1.2k
E. A. B. McCruden United Kingdom 11 367 0.5× 225 0.4× 69 1.0× 13 0.2× 25 0.7× 15 528
Andrea Mariano Italy 15 813 1.2× 708 1.1× 170 2.5× 7 0.1× 26 0.7× 34 1.0k

Countries citing papers authored by Masaaki Mizui

Since Specialization
Citations

This map shows the geographic impact of Masaaki Mizui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Mizui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Mizui more than expected).

Fields of papers citing papers by Masaaki Mizui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Mizui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Mizui. The network helps show where Masaaki Mizui may publish in the future.

Co-authorship network of co-authors of Masaaki Mizui

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Mizui. A scholar is included among the top collaborators of Masaaki Mizui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Mizui. Masaaki Mizui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuo, Junko, Masaaki Mizui, Keiko Katayama, et al.. (2012). Follow up of the 987 blood donors found with hepatitis C virus infection over 9–18 years. Hepatology Research. 42(7). 637–647. 8 indexed citations
2.
Tanaka, Junko, Tomiko Koyama, Masaaki Mizui, et al.. (2011). Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale. Intervirology. 54(4). 185–195. 121 indexed citations
3.
Tanaka, Junko, Keiko Katayama, Masaaki Mizui, et al.. (2008). Titration of hepatitis B virus infectivity in the sera of pre‐acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes. Journal of Medical Virology. 80(12). 2064–2068. 52 indexed citations
4.
Tanaka, Junko, Masaaki Mizui, Keiko Katayama, et al.. (2008). Incidence Rates of Hepatitis B and C Virus Infections among Blood Donors in Hiroshima, Japan, during 10 Years from 1994 to 2004. Intervirology. 51(1). 33–41. 26 indexed citations
5.
Komiya, Yutaka, Keiko Katayama, Hisao Yugi, et al.. (2007). Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion. 48(2). 286–294. 73 indexed citations
6.
Yugi, Hisao, Masaaki Mizui, Junko Tanaka, & Hiroshi Yoshizawa. (2006). Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing — Japanese experience. Journal of Clinical Virology. 36. S56–S64. 28 indexed citations
7.
Tanaka, Junko, Keiko Katayama, Junko Kumagai, et al.. (2005). Early Dynamics of Hepatitis C Virus in the Circulation of Chimpanzees with Experimental Infection. Intervirology. 48(2-3). 120–123. 8 indexed citations
8.
Katayama, Keiko, Junko Kumagai, Yutaka Komiya, et al.. (2004). Titration of Hepatitis C Virus in Chimpanzees for Determining the Copy Number Required for Transmission. Intervirology. 47(1). 57–64. 41 indexed citations
9.
Tanaka, Junko, Junko Kumagai, Keiko Katayama, et al.. (2004). Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000. Intervirology. 47(1). 32–40. 150 indexed citations
10.
Tanaka, Junko, Hiromitsu Kumada, Kenji Ikeda, et al.. (2003). Natural histories of hepatitis C virus infection in men and women simulated by the Markov model. Journal of Medical Virology. 70(3). 378–386. 34 indexed citations
11.
Katayama, Keiko, Junko Tanaka, Naofumi Ohno, et al.. (2003). Lack of Epidemiological Evidence for a Role of Resolved Hepatitis B Virus Infection in Hepatocarcinogenesis in Patients Infected with Hepatitis C Virus in Japan. Intervirology. 46(3). 171–176. 13 indexed citations
12.
Mima, Satoaki, et al.. (1995). Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti‐hepatitis B core antibody. Journal of Medical Virology. 46(3). 201–206. 32 indexed citations
13.
Moriya, Takashi, Masaaki Mizui, Naofumi Ohno, et al.. (1995). Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomedicine & Pharmacotherapy. 49(2). 59–64. 73 indexed citations
14.
Mizui, Masaaki. (1994). Relation between HCV genotypes and the prevalence of antibodies against 5-1-1 and C100-3 in Japanese blood donors seropositive for hepatitis C virus. International Hepatology Communications. 2(3). 183–185. 2 indexed citations
15.
Ichimura, Hiroshi, I. Tamura, Osamu Kurimura, et al.. (1994). Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. Journal of Medical Virology. 43(3). 212–215. 27 indexed citations
16.
Mizui, Masaaki, Tatsumi Moriya, Hiroshi Yoshizawa, et al.. (1994). A Novel Agglutination Method for Screening of HIV and HCV Antibody Testing with 5‐μl Reagents: Reduction of Cost and Time with High Sensitivity. Vox Sanguinis. 67(3). 315–316. 4 indexed citations
17.
Tanaka, Junko, et al.. (1993). [Prevalence of anti C100-3 and HBsAg in blood donors--comparative study of total collected blood units, total collection adjusted to exclude repeat blood donations, and in first time blood donors].. PubMed. 40(7). 540–6. 4 indexed citations
18.
Watanabe, J, Chieko Matsumoto, K Nishioka, et al.. (1993). Predictive Value of Screening Tests for Persistent Hepatitis C Virus Infection Evidenced by Viraemia: Japanese Experience. Vox Sanguinis. 65(3). 199–203. 51 indexed citations
19.
Ouchi, Kazunobu, et al.. (1991). Prevalence of antibody to Chlamydia pneumoniae TWAR in japan. Journal of Clinical Microbiology. 29(4). 816–818. 61 indexed citations
20.
Kuroda, Yoshinori, et al.. (1980). [Clinical results of cefoperazone in pediatric infections (author's transl)].. PubMed. 33(9). 931–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martí Vall Breakdown of academic impact, for papers by José María Sánchez-Tapias Breakdown of academic impact, for papers by Vincenzo Guadagnino Breakdown of academic impact, for papers by Zelma Buskell‐Bales Breakdown of academic impact, for papers by Rabab Fouad Breakdown of academic impact, for papers by J. Camps Breakdown of academic impact, for papers by L Viladomiu Breakdown of academic impact, for papers by David Ipe Breakdown of academic impact, for papers by E. A. B. McCruden Breakdown of academic impact, for papers by Andrea Mariano
Rankless by CCL
2026